Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
1.
Mol Pharmacol ; 62(1): 58-64, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12065755

RESUMEN

Transforming growth factor beta1 (TGF-beta1) is a potent fibrotic factor responsible for the synthesis of extracellular matrix. TGF-beta1 acts through the TGF-beta type I and type II receptors to activate intracellular mediators, such as Smad proteins, the p38 mitogen-activated protein kinase (MAPK), and the extracellular signal-regulated kinase pathway. We expressed the kinase domain of the TGF-beta type I receptor [activin receptor-like kinase (ALK)5] and the substrate, Smad3, and determined that SB-431542 is a selective inhibitor of Smad3 phosphorylation with an IC50 of 94 nM. It inhibited TGF-beta1-induced nuclear Smad3 localization. The p38 mitogen-activated protein kinase inhibitors SB-203580 and SB-202190 also inhibit phosphorylation of Smad3 by ALK5 with IC50 values of 6 and 3 microM, respectively. This suggests that these p38 MAPK inhibitors must be used at concentrations of less than 10 microM to selectively address p38 MAPK mechanisms. However, the p38 MAPK inhibitor SB-242235 did not inhibit ALK5. To evaluate the relative contribution of Smad signaling and p38 MAPK signaling in TGF-beta1-induced matrix production, the effect of SB-431542 was compared with that of SB-242235 in renal epithelial carcinoma A498 cells. All compounds inhibited TGF-beta1-induced fibronectin (FN) mRNA, indicating that FN synthesis is mediated in part via the p38 MAPK pathway. In contrast, SB-431542, but not the selective p38 MAPK inhibitor SB-242235, inhibited TGF-beta1-induced collagen Ialpha1 (col Ialpha1). These data indicate that some matrix markers that are stimulated by TGF-beta1 are mediated via the p38 MAPK pathway (i.e., FN), whereas others seem to be activated via ALK5 signaling independent of the p38 MAPK pathway (i.e., col Ialpha1).


Asunto(s)
Benzamidas/farmacología , Dioxoles/farmacología , Inhibidores Enzimáticos/farmacología , Matriz Extracelular/metabolismo , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Factor de Crecimiento Transformador beta/antagonistas & inhibidores , Receptores de Activinas Tipo I/metabolismo , Colágeno Tipo I/genética , Colágeno Tipo I/metabolismo , Matriz Extracelular/efectos de los fármacos , Fibronectinas/metabolismo , Humanos , Imidazoles/farmacología , Proteínas Quinasas Activadas por Mitógenos/antagonistas & inhibidores , Inhibidor 1 de Activador Plasminogénico/genética , Inhibidor 1 de Activador Plasminogénico/metabolismo , Piridinas/farmacología , ARN Mensajero/efectos de los fármacos , ARN Mensajero/metabolismo , Receptor Tipo I de Factor de Crecimiento Transformador beta , Receptores de Factores de Crecimiento Transformadores beta/metabolismo , Trombospondina 1/genética , Trombospondina 1/metabolismo , Factor de Crecimiento Transformador beta1 , Células Tumorales Cultivadas , Proteínas Quinasas p38 Activadas por Mitógenos
2.
Br J Pharmacol ; 134(5): 977-84, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11682445

RESUMEN

1. The effect of carvedilol on renal function, structure and expression of TGF beta and the matrix proteins fibronectin, collagen I and collagen III, was evaluated in spontaneously hypertensive stroke-prone (SHR-SP) rats fed a high fat, high salt diet. 2. Carvedilol treatment for 11 to 18 weeks did not alter systolic blood pressure in SHR-SP rats, however, it resulted in a significant reduction in heart rate. 3. Carvedilol treatment reduced renal fibrosis and total, active and chronic renal damage to levels approaching those of WKY rats on a normal diet. 4. Urinary protein excretion was higher in SHR-SP rats (51+/-10 mg day(-1)) than WKY rats (18+/-2 mg day(-1)) and this was further increased when SHR-SP rats were fed a high fat, high salt diet (251+/-120 mg day(-1)). Treatment with carvedilol resulted in significantly lower urinary protein excretion (37+/-15 mg day(-1)). 5. The expression of TGF beta mRNA was significantly higher in SHR-SP rats compared to WKY rats and a further increase was observed when rats were fed a high fat, high salt diet. Renal TGF beta expression was significantly reduced by treatment with carvedilol. The expression of fibronectin and collagen I and collagen III mRNA showed a pattern similar to that observed with TGF beta mRNA expression. Collagen I mRNA expression followed a pattern similar to renal fibrosis. 6. These data indicate that carvedilol can provide significant renal protection in the absence of any antihypertensive activity and that the mechanisms involved in this action may include reduced expression of profibrotic factors such as TGF beta.


Asunto(s)
Antagonistas Adrenérgicos beta/farmacología , Carbazoles/farmacología , Hipertensión/fisiopatología , Riñón/efectos de los fármacos , Propanolaminas/farmacología , Factor de Crecimiento Transformador beta/genética , Animales , Presión Sanguínea/efectos de los fármacos , Carvedilol , Colágeno Tipo I/genética , Grasas de la Dieta/administración & dosificación , Femenino , Fibronectinas/genética , Fibrosis , Regulación de la Expresión Génica/efectos de los fármacos , Frecuencia Cardíaca/efectos de los fármacos , Hipertensión/genética , Riñón/metabolismo , Riñón/patología , Masculino , ARN Mensajero/efectos de los fármacos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Índice de Severidad de la Enfermedad , Cloruro de Sodio Dietético/administración & dosificación
3.
Nutr Cancer ; 39(1): 58-65, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11588903

RESUMEN

Lignans, similar in structure to endogenous sex steroid hormones, may act in vivo to alter hormone metabolism and subsequent cancer risk. The objective of this study was to examine effects of dietary intake of a lignan-rich plant food (flaxseed) on serum concentrations of endogenous hormones and binding proteins (estrone, estrone sulfate, 17 beta-estradiol, sex hormone-binding globulin, progesterone, prolactin, dehydroepiandrosterone sulfate, dehydroepiandrosterone, androstenedione, testosterone, and free testosterone) in postmenopausal women. This randomized, crossover trial consisted of three seven-week feeding periods, during which 28 postmenopausal women, aged 52-82 yr, consumed their habitual diets plus 0, 5, or 10 g of ground flaxseed. Serum samples collected during the last week of each feeding period were analyzed for serum hormones using standard diagnostic kits. The flaxseed diets significantly reduced serum concentrations of 17 beta-estradiol by 3.26 pg/ml (12.06 pmol/l) and estrone sulfate by 0.09 ng/ml (0.42 nmol/l) and increased prolactin by 1.92 micrograms/l (0.05 IU/ml). Serum concentrations of androstenedione, estrone, sex hormone-binding globulin, progesterone, testosterone, free testosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate were not altered with flaxseed feeding. In this group of postmenopausal women, consuming flaxseed in addition to their habitual diets influenced their endogenous hormone metabolism by decreasing serum 17 beta-estradiol and estrone sulfate and increasing serum prolactin concentrations.


Asunto(s)
Estrona/análogos & derivados , Lino/metabolismo , Hormonas/sangre , Lignanos/metabolismo , Posmenopausia/sangre , Anciano , Anciano de 80 o más Años , Estudios Cruzados , Estradiol/sangre , Estrona/sangre , Femenino , Humanos , Persona de Mediana Edad , Posmenopausia/metabolismo , Prolactina/sangre
4.
Physiol Genomics ; 4(1): 35-42, 2000 Nov 09.
Artículo en Inglés | MEDLINE | ID: mdl-11074011

RESUMEN

The role of ANG II on renal and cardiac gene expression of matrix proteins was studied in rats with progressive renal disease. Induction of renal failure by five-sixths nephrectomy of Sprague-Dawley rats resulted in hypertension (163 +/- 19 vs. control pressures of 108 +/- 6 mmHg), proteinuria (83 +/- 47 vs. 14 +/- 2 mg/day), and increased renal expression of fibronectin, thrombospondin, collagen I and III, transforming growth factor-beta (TGF-beta), and plasminogen activator inhibitor-1 (PAI-1) mRNA. Treatment with the ANG II receptor antagonist, eprosartan (60 mg. kg(-1).day(-1)), lowered blood pressure (95 +/- 5 mmHg) and proteinuria (19 +/- 8 mg/d) and abrogated the increased TGF-beta, fibronectin, thrombospondin, collagens I and III, and PAI-1 mRNA expression. An increase in left ventricular weight was observed in five-sixths nephrectomized rats (0.13 +/- 0.01 vs. 0.08 +/- 0.01 g/100 g body wt), a response that was inhibited by eprosartan treatment (0.10 +/- 0.01 g/100 g). Left ventricular expression of TGF-beta and fibronectin was also increased in rats with renal disease; however, the small decreases in expression observed in eprosartan-treated rats did not reach statistical significance. These data suggest that eprosartan may be beneficial in progressive renal disease and that the mechanism of action includes inhibition of cytokine production in addition to antihypertensive activity.


Asunto(s)
Acrilatos/farmacología , Antagonistas de Receptores de Angiotensina , Antihipertensivos/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Imidazoles/farmacología , Enfermedades Renales/tratamiento farmacológico , Enfermedades Renales/genética , Tiofenos , Animales , Hipertensión/tratamiento farmacológico , Hipertensión/etiología , Hipertensión/genética , Masculino , Nefrectomía , Proteinuria/tratamiento farmacológico , Proteinuria/etiología , Proteinuria/genética , Ratas , Ratas Sprague-Dawley
5.
Cancer Epidemiol Biomarkers Prev ; 9(10): 1113-8, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11045796

RESUMEN

Dietary estrogens, such as lignans, are similar in structure to endogenous sex steroid hormones and may act in vivo to alter hormone metabolism and subsequent cancer risk. The objective of this study was to examine the effect of dietary intake of a lignan-rich plant food (flaxseed) on urinary lignan excretion in postmenopausal women. This randomized, cross-over trial consisted of three 7-week feeding periods during which 31 healthy postmenopausal women, ages 52-82 years, consumed their habitual diets plus 0, 5, or 10 grams of ground flaxseed per day. Urine samples collected for 2 consecutive days during the last week of each feeding period were analyzed for lignan content (enterodiol, enterolactone, and matairesinol) by isotope dilution gas chromatography/mass spectrometry. Compared with the 0-gram flaxseed diet, consumption of 5 or 10 grams of flaxseed significantly increased excretion of enterodiol by 1,009 and 2,867 nmol/day, respectively; significantly increased excretion of enterolactone by 21,242 and 52,826 nmol/day, respectively; and significantly increased excretion of total lignans (enterodiol + enterolactone + matairesinol) by 24,333 and 60,640 nmol/day, respectively. Excretion of matairesinol was not significantly altered by flaxseed consumption. Consumption of flax, a significant source of dietary estrogens, in addition to their habitual diets increased excretion of enterodiol and enterolactone, but not matairesinol, in a dose-dependent manner in this group of postmenopausal women. Urinary excretion of lignan metabolites is a dose-dependent biomarker of flaxseed intake within the context of a habitual diet.


Asunto(s)
Lino , Lignanos/orina , Posmenopausia , Anciano , Biomarcadores/análisis , Estudios Cruzados , Dieta , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Persona de Mediana Edad
6.
J Air Waste Manag Assoc ; 50(4): 484-7, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10785998

RESUMEN

A low-flow rate, sharp cut point inertial impaction sampler was developed in 1986 that has been widely used in PM exposure studies in the United States and several other countries. Although sold commercially as the MS&T Area Sampler, this sampler is widely referred to as the Harvard Impactor, since the initial use was at the Harvard School of Public Health. Impactor nozzles for this sampler have been designed and characterized for flows of 4, 10, 20, and 23 L/min and cut points of 1, 2, 5, and 10 microns. An improved method for determining the actual collecting efficiency curve was developed and used for the recent impactor calibrations reported here. It consists of placing a multiplet reduction impactor inline just downstream of the vibrating orifice aerosol generator to remove the multiplets, thus allowing only the singlet particle s to penetrate through to the impactor being calibrated This paper documents the techniques and results of recent nozzle calibrations for this sampler and compares it with other size-selective inertial impactors. In general, the impactors were found to have sharp cutoff characteristics. Particle interstage losses for all of the impactors were very low, with the exception of the 10-micron cut size 20 L/min impactor, which had greater losses due to the higher flow rate. All of the 2.5-micron cut nozzle laboratory calibrations compare favorably to the U.S. Environmental Protection Agency (EPA) WINS-96 fine particle mass (PM2.5) impactor calibration data.


Asunto(s)
Contaminación del Aire Interior/análisis , Monitoreo del Ambiente/instrumentación , Calibración , Humanos , Tamaño de la Partícula , Salud Pública , Sensibilidad y Especificidad
7.
J Appl Physiol (1985) ; 88(4): 1316-20, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10749825

RESUMEN

It has been suggested there is a decreased renal responsiveness to vasopressin following spaceflight and that this may be the mechanism for the increased urine flow that is observed following return to normal gravity. In the present study, we have therefore measured vasopressin receptor expression and activity in kidneys taken from rats 1 and 14 days following spaceflight of 15 days duration. Measurements of renal vasopressin V(2) and V(1a) receptor mRNA expression by quantitative RT-PCR demonstrated little difference at either 1 day or at 14 days following return from space. Evaluation of (3)H-labeled arginine vasopressin binding to membranes prepared from kidneys indicated that the majority of the vasopressin receptors were V(2) receptors. Furthermore, the data suggested that binding to vasopressin V(2) or V(1a) receptors was unaltered at 1 day and 14 days following spaceflight. Similarly, the ability of vasopressin to stimulate adenylate cyclase suggested no change in vasopressin V(2) receptor activity in these animals. These data suggest that, whatever changes in fluid and electrolyte metabolism are observed following spaceflight, they are not mediated by changes in vasopressin receptor number or vasopressin-induced stimulation of adenylate cyclase.


Asunto(s)
Regulación de la Expresión Génica , Riñón/fisiología , Receptores de Vasopresinas/genética , Receptores de Vasopresinas/fisiología , Vuelo Espacial , Simulación del Espacio , Animales , Arginina Vasopresina/metabolismo , Peso Corporal , Gravitación , Masculino , Ratas , Ratas Endogámicas F344 , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Tiempo
8.
Biochem Pharmacol ; 59(7): 847-53, 2000 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-10718343

RESUMEN

The potential role of hepatocyte growth factor (HGF) in regulating extracellular matrix in mouse mesangial cells (MMC) was evaluated. Functional HGF receptors were deed in MMC by HGF-induced extracellular acidification, a response that was inhibited by the HGF inhibitor HGF/NK2, a splice variant expressing the N-terminal domain through the second kringle domain HGF also increased fibronectin and collagen alpha1 (IV) mRNA levels in these cells; the increases were associated with a concentration-dependent increase in transcriptional activity of the collagen alpha1 (IV) gene. HGF also stimulated fibronectin and collagen alpha1 (IV) mRNA levels in primary rabbit proximal tubule epithelial cells To evaluate the potential consequences of chronic elevation of HGF on renal fuction, HGF was administered continuously for 18 days to normal and diabetic C57BLKS/J lepr(db) mice. In the diabetic mice, HGF reduced creatinine clearance and increased microalbuminuria, indicating that chronic exposure to HGF impairs renal function. Thus, chronically elevated HGF may contribute to the progression of chronic renal disease in diabetes by decreasing the glomerular filtration rate and possibly promoting the accumulation of extracellular matrix.


Asunto(s)
Matriz Extracelular/genética , Regulación de la Expresión Génica , Mesangio Glomerular/fisiología , Factor de Crecimiento de Hepatocito/fisiología , Animales , Células Cultivadas , Colágeno/genética , Colágeno/metabolismo , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/fisiopatología , Matriz Extracelular/metabolismo , Fibronectinas/genética , Fibronectinas/metabolismo , Mesangio Glomerular/citología , Humanos , Pruebas de Función Renal , Túbulos Renales/metabolismo , Ratones , Ratones Endogámicos C57BL , Regiones Promotoras Genéticas , Proteínas Proto-Oncogénicas c-met/análisis , Conejos
9.
J Am Soc Nephrol ; 10(12): 2488-94, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10589686

RESUMEN

Differential display PCR was used to identify alternate expression of serum glucocorticoid-regulated kinase (Sgk) mRNA in diabetes-induced renal disease. Differential expression of Sgk mRNA was identified in the kidneys of normal and obese db/db mice, a model of select aspects of human diabetic nephropathy. Sgk mRNA was selectively increased in diabetic mouse kidneys. The Sgk mRNA levels remained constant in other tissues from obese db/db mice. An increase in Sgk mRNA was also observed in the human diabetic kidney. In addition, thrombin, which may play a role in the progression of renal disease, increased Sgk message in cell culture. Because the diabetes-induced increase in Sgk was only observed in the kidney, which is particularly susceptible to diabetes-induced damage, Sgk may play a role in diabetic nephropathy.


Asunto(s)
Nefropatías Diabéticas/enzimología , Nefropatías Diabéticas/genética , Riñón/enzimología , Proteínas Nucleares , Proteínas Serina-Treonina Quinasas/genética , Animales , Secuencia de Bases , Células Cultivadas , Cartilla de ADN/genética , Expresión Génica/efectos de los fármacos , Humanos , Proteínas Inmediatas-Precoces , Ratones , Ratones Endogámicos C57BL , Ratones Obesos , Reacción en Cadena de la Polimerasa , ARN Mensajero/genética , ARN Mensajero/metabolismo , Especificidad de la Especie , Trombina/farmacología , Distribución Tisular
10.
Nutr Cancer ; 33(2): 188-95, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10368815

RESUMEN

Flaxseed, the richest known source of plant lignans, has been shown to have chemoprotective effects in animal and cell studies. Some of its effects may be mediated through its influence on endogenous hormone production and metabolism. Two competing pathways in estrogen metabolism involve production of the 2-hydroxylated and 16 alpha-hydroxylated metabolites. Because of the proposed differences in biological activities of these metabolites, the balance of the two pathways has been used as a biomarker for breast cancer risk. We examined the effects of flaxseed consumption on urinary estrogen metabolite excretion in postmenopausal women. Twenty-eight postmenopausal women were studied for three seven-week feeding periods in a randomized crossover design. During the feeding periods, subjects consumed their usual diets plus ground flaxseed (0, 5, or 10 g/day). Urinary excretion of the estrogen metabolites 2-hydroxyestrogen (2-OHEstrogen) and 16 alpha-hydroxyestrone (16 alpha-OHE1) as well as their ratio, 2/16 alpha-OHE1, was measured by enzyme immunoassay. Flaxseed supplementation significantly increased urinary 2-OHEstrogen excretion (p < 0.0005) and the urinary 2/16 alpha-OHE1 ratio (p < 0.05) in a linear, dose-response fashion. There were no significant differences in urinary 16 alpha-OHE1 excretion. These results suggest that flaxseed may have chemoprotective effects in postmenopausal women.


Asunto(s)
Estrógenos/orina , Lino , Lignanos/farmacología , Posmenopausia , Semillas , Anciano , Anciano de 80 o más Años , Estudios Cruzados , Femenino , Humanos , Lignanos/administración & dosificación , Persona de Mediana Edad
11.
Pharmacology ; 58(4): 200-8, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10077739

RESUMEN

Age-related increases occurred in renal thrombospondin 1 (TSP1) mRNA in F344 rats, resembling diabetes-induced TSP1 mRNA in the obese Zucker rat. TSP1 mRNA was 3.5-fold higher in 24-month-old than in 3-month-old F344 rats. TSP1 mRNA increased similarly in 5-month-old obese Zucker rats as compared with lean littermates and correlated positively with the extent of proteinuria (r = 0.71). In situ hybridization identified elevated TSP1 mRNA levels in epithelial cells of distended tubules as well as in interstitium near dilated tubules of both 24-month-old F344 rats and 5-month-old obese Zucker rats. Furthermore, thrombin increased TSP1 mRNA in mesangial and epithelial cells in culture, indicating that thrombin may contribute to elevated TSP1 expression in renal disease. Thrombin increased TSP1 mRNA within 30 min after treatment which required de novo synthesis of protein. The thrombin receptor tethered ligand peptide, SFLLRN, increased TSP1 mRNA, indicating that the thrombin-induced increase in TSP1 mRNA was due to direct thrombin receptor (PAR1) stimulation. These results show that increased TSP1 mRNA levels are a component of interstitial fibrosis seen in aged and diabetic kidneys and suggest that similar pathological changes occur in kidneys of aging and diabetic rats.


Asunto(s)
Envejecimiento , Riñón/metabolismo , ARN Mensajero/metabolismo , Trombospondina 1/genética , Animales , Northern Blotting , Línea Celular , Cicloheximida/farmacología , Complicaciones de la Diabetes , Diabetes Mellitus/etiología , Diabetes Mellitus/metabolismo , Neuropatías Diabéticas/metabolismo , Células Epiteliales/citología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Regulación del Desarrollo de la Expresión Génica , Mesangio Glomerular/citología , Mesangio Glomerular/efectos de los fármacos , Mesangio Glomerular/metabolismo , Hemostáticos/farmacología , Hibridación in Situ , Riñón/citología , Riñón/patología , Masculino , Obesidad , Fragmentos de Péptidos/farmacología , Inhibidores de la Síntesis de la Proteína/farmacología , ARN Mensajero/efectos de los fármacos , ARN Mensajero/genética , Ratas , Ratas Endogámicas F344 , Ratas Zucker , Trombina/farmacología
12.
Pharmacology ; 57(1): 13-9, 1998 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9670208

RESUMEN

The effect of the angiotensin-converting enzyme inhibitor captopril on clusterin mRNA was examined in partially nephrectomized male rats. Urine protein excretion was measured 3, 7, and 28 days after removal of five sixths of the renal mass. Nephrectomy caused a progressive increase in clusterin mRNA levels in the remnant kidney. Maximal clusterin mRNA levels occurred 7 days after nephrectomy and declined 28 days after nephrectomy. Captopril, 250 mg/ml in drinking water, prevented the injury-induced increase in clusterin mRNA at 7 and 28 days. Captopril had no effect on clusterin in sham-operated rats. As expected, the urine protein excretion increased progressively after nephrectomy, and this was attenuated by administration of captopril in the drinking water. Therefore, clusterin is a marker of renal injury which, along with proteinuria, is modulated by angiotensin-converting enzyme inhibition.


Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Captopril/farmacología , Glicoproteínas/efectos de los fármacos , Riñón/efectos de los fármacos , Chaperonas Moleculares , ARN Mensajero/efectos de los fármacos , Animales , Northern Blotting , Clusterina , Expresión Génica/efectos de los fármacos , Expresión Génica/genética , Glicoproteínas/genética , Riñón/metabolismo , Riñón/cirugía , Masculino , Nefrectomía , Peptidil-Dipeptidasa A/efectos de los fármacos , Proteinuria/orina , ARN Mensajero/genética , Ratas , Ratas Sprague-Dawley , Factores de Tiempo
13.
Pharmacology ; 57(1): 20-7, 1998 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9670209

RESUMEN

Evidence suggests that transforming growth factor beta 1 (TGF-beta 1), a multifunctional cytokine, induces renal extracellular matrix production and glomerular hypertrophy. The aim of the present study was to investigate the effect of captopril on the expression of TGF-beta 1 mRNA in a rat model of chronic renal failure: five-sixths nephrectomy. Chronic renal disease was induced by removal of the right kidney and ligation of three blood vessels supplying the left kidney. Sham-operated animals were used as controls. RNA was extracted from the viable remnant kidney of rats 1 day and 1 and 2 weeks following five-sixths nephrectomy and from the kidneys of rats who underwent sham surgery. TGF-beta 1 mRNA was induced within 24 h of partial nephrectomy, similar to that reported for early-onset genes. Subsequently, TGF-beta 1 mRNA expression continued to increase over the next 2-4 weeks. The upregulation of TGF-beta 1 correlated with the degree of proteinuria. Both the increase in TGF-beta 1 mRNA and proteinuria were abrogated by captopril treatment. In addition, no change in expression of ALK-5 or type II TGF-beta receptors following five-sixths nephrectomy was observed. These data suggest that captopril may protect against development of glomerulosclerosis and proteinuria by reducing TGF-beta 1 expression and hence matrix production.


Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Captopril/farmacología , Fallo Renal Crónico/orina , Proteinuria/orina , ARN Mensajero/efectos de los fármacos , Factor de Crecimiento Transformador beta/efectos de los fármacos , Animales , Northern Blotting , Modelos Animales de Enfermedad , Expresión Génica/efectos de los fármacos , Expresión Génica/genética , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/cirugía , Corteza Renal/efectos de los fármacos , Corteza Renal/metabolismo , Fallo Renal Crónico/genética , Nefrectomía , Peptidil-Dipeptidasa A/efectos de los fármacos , ARN Mensajero/genética , Ratas , Receptores de Factores de Crecimiento Transformadores beta/genética , Factor de Crecimiento Transformador beta/genética
14.
Biochem Pharmacol ; 55(2): 227-34, 1998 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-9448746

RESUMEN

Hepatocyte growth factor (HGF) induces mitogenesis, chemotaxis, and tubule formation in renal epithelial cells. This study examined the effects of wortmannin and protein kinase C (PKC) inhibitors on HGF-mediated changes in metabolic activity in glomerular mesangial cells and renal epithelial carcinoma A498 cells. The extracellular acidification rate of transformed mouse glomerular mesangial cells and A498 cells was measured as an index of metabolic activity with a microphysiometer. HGF increased the acidification rate of mesangial cells and A498 cells in a concentration-dependent fashion that was inhibited completely by the tyrosine kinase inhibitor tyrophostin-23 (100 microM). The PKC inhibitors RO-32-0432 and SKF-57048 also inhibited HGF-induced acidification. The IC50 values for SKF-57048 were 59 +/- 2 and 20 +/- 10 nM in mesangial cells and A498 cells, respectively (P < 0.05). 12-O-Tetradecanoylphorbol 13-acetate (TPA), a phorbol ester that activates PKC, increased acidification in mesangial and epithelial cells similar to HGF. Wortmannin, an inhibitor of phosphatidylinositol (PI) 3-kinase (IC50 value 1-10 nM), inhibited HGF-induced acidification with an IC50 of 93 +/- 31 and 9 +/- 1 nM in mesangial and A498 cells, respectively (P < 0.05). In contrast, there was no significant difference in the IC50 value of wortmannin for epidermal growth factor (EGF)-induced acidification between mesangial and A498 cells (23 +/- 9 vs 14 +/- 1 nM, respectively). Because the IC50 value for wortmannin in inhibiting HGF but not EGF-induced acidification was an order of magnitude higher in mesangial cells than in epithelial A498 cells, a wortmannin-sensitive PI 3-kinase pathway may not be involved in HGF-mediated acidification in mesangial cells.


Asunto(s)
Mesangio Glomerular/fisiología , Factor de Crecimiento de Hepatocito/farmacología , Proteína Quinasa C/metabolismo , Proteínas Tirosina Quinasas/metabolismo , Tirfostinos , Androstadienos/farmacología , Animales , Catecoles/farmacología , Células Cultivadas , Criopreservación , Inhibidores Enzimáticos/farmacología , Factor de Crecimiento Epidérmico/farmacología , Mesangio Glomerular/citología , Mesangio Glomerular/efectos de los fármacos , Humanos , Concentración de Iones de Hidrógeno , Neoplasias Renales , Cinética , Ratones , Ratones Endogámicos , Nitrilos/farmacología , Fosfatidilinositol 3-Quinasas/metabolismo , Reacción en Cadena de la Polimerasa , Proteínas Proto-Oncogénicas c-met/biosíntesis , ARN Mensajero/biosíntesis , Acetato de Tetradecanoilforbol/farmacología , Transcripción Genética/efectos de los fármacos , Células Tumorales Cultivadas , Wortmanina
15.
J Am Soc Nephrol ; 9(1): 38-45, 1998 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9440085

RESUMEN

Clusterin is a multifunctional glycoprotein associated with development and tissue injury. Because renal function decreases with advancing age in the obese Zucker rat, clusterin mRNA expression was examined in the kidney of young adult Zucker rats and compared with age-related changes in renal clusterin mRNA expression in Fischer 344 (F344) rats. Renal clusterin mRNA levels in the obese Zucker rat were 2.5-fold higher by 3 mo of age and fourfold higher at 5 mo of age compared with the lean strain. In comparison, renal clusterin mRNA in 12-mo-old F344 rats was twofold higher than in 3-mo-old animals and was tenfold higher at 24 mo of age. Clusterin mRNA was positively correlated with urinary protein excretion and negatively correlated with creatinine clearance in Zucker rats. Clusterin was increased in select nephrons of the obese Zucker rat kidney and in 24-mo-old F344 rat kidney as assessed by in situ hybridization. Increased expression of clusterin mRNA occurred mostly in the tubular epithelium of dilated, convoluted proximal tubules. These data indicate that renal clusterin mRNA levels increase as a function of age and that age-related increases in renal clusterin and the associated tubular abnormalities are accelerated in obese Zucker rats.


Asunto(s)
Envejecimiento/metabolismo , Glicoproteínas/genética , Riñón/metabolismo , Chaperonas Moleculares , Obesidad/metabolismo , ARN Mensajero/metabolismo , Ratas Zucker/metabolismo , Animales , Northern Blotting , Clusterina , Hibridación in Situ , Masculino , Ratas , Ratas Endogámicas F344/metabolismo , Distribución Tisular
16.
J Aerosol Med ; 11 Suppl 1: S139-53, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-10180727

RESUMEN

Design theory for cascade impactors is well developed, and design principles can be summarized quite succinctly. The key geometric parameters of three commonly used impactors have been compared to design guidelines. Calibration theory and practice have undergone improvement in recent years. Published results show distinctly different characteristics for three commonly used impactors, and conformance to modern design recommendations results in desirable performance characteristics. A consideration of the sensitivity of stage collection efficiency characteristics to geometric variables and flow rate indicates that measurement of certain physical dimensions is sufficient to assure that impactor performance matches that of a properly calibrated unit. Flow rate is an important operating variable that is more likely to fall out of its calibrated range than important dimensional variables resulting from instrument manufacturing. In practice, data from impactors are frequently treated as though the impactors have ideal collection characteristics. The practical effects of impactor nonideal performance can be demonstrated by model calculations, and these show the necessity of data inversion to obtain a size distribution. The process is not straightforward for unknown distributions. There are much smaller differences between ideal and real performance for an impactor complying with design guidelines, thus, the cutoff characteristics are sharp.


Asunto(s)
Aerosoles/administración & dosificación , Sistemas de Liberación de Medicamentos , Nebulizadores y Vaporizadores , Calibración , Diseño de Equipo , Humanos , Tamaño de la Partícula
17.
J Am Soc Nephrol ; 8(6): 906-14, 1997 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9189857

RESUMEN

Clusterin, a multifunctional protein with complement blocking activity, and fibrin, a product of thrombin's enzymatic activity, are present in the kidney during acute and chronic renal failure. The role of thrombin in regulating clusterin mRNA in the kidney is not known. The effect of thrombin on clusterin mRNA expression was examined in rat glomerular mesangial and glomerular epithelial cells, and cultured human renal proximal tubular epithelial cells by northern blot. Thrombin (10(-8) M) increased clusterin mRNA levels two- to fourfold in glomerular mesangial, glomerular epithelial, and proximal tubule epithelial cells. This was a specific effect of thrombin receptor activation because peptides corresponding to the tethered ligand of the thrombin receptor were also able to increase clusterin mRNA levels. Epidermal growth factor, insulin-like growth factor-1, and transforming growth factor-beta 1 had little or no effect on clusterin mRNA levels. The protein kinase C inhibitor RO-32-0432 (1 microM) inhibited the thrombin-induced increase in clusterin mRNA, suggesting that thrombin receptor activation may regulate renal clusterin mRNA levels through protein kinase C.


Asunto(s)
Proteínas Inactivadoras de Complemento/genética , Mesangio Glomerular/metabolismo , Glicoproteínas/genética , Glomérulos Renales/metabolismo , Chaperonas Moleculares , ARN Mensajero/metabolismo , Trombina/farmacología , Animales , Células Cultivadas , Clusterina , AMP Cíclico/fisiología , Células Epiteliales , Epitelio/metabolismo , Mesangio Glomerular/citología , Humanos , Inmunohistoquímica , Hibridación in Situ , Glomérulos Renales/citología , Proteína Quinasa C/fisiología , Ratas
18.
J Am Coll Nutr ; 16(6): 570-7, 1997 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9430085

RESUMEN

OBJECTIVE: In an attempt to improve the nutritional value of animal fats (including milkfat and lard), two technological approaches (i.e., cholesterol removal by steam distillation and linoleic acid enrichment by addition of safflower oil) were tested for cholesterolemic effects in a cohort of 29 older women (age 68 +/- 7 years). METHODS: Test fat sources were incorporated into crackers, cookies, cheese, ice cream, whipped topping, sour cream, baking shortening, and table spreads. Subjects were permanent residents of a convent where meals were prepared in a centralized kitchen, allowing test fats to be provided in daily food menu items. The foods containing test fats were introduced into three sequential dietary treatment periods, each lasting 4 weeks, in the following order: cholesterol-reduced animal fat (CRAF): fatty-acid modified, cholesterol-reduced animal fat (FAMCRAF); and-unaltered animal fat (AF). Subjects were offered menu items cafeteria style and encouraged to make food selections consistent with their habitual diets, which were recorded daily. RESULTS: Fasted blood lipid profiles determined at the end of each treatment period showed that FAMCRAF reduced mean plasma total cholesterol, LDL cholesterol, and apolipoprotein B concentrations relative to AF (p < 0.05). Mean HDL cholesterol concentrations were not influenced by diet. DISCUSSION: Relative to native products, animal fats modified by cholesterol removal and linoleic acid enrichment reduced plasma total and LDL cholesterol concentrations in a predictable manner similar to that based on studies of men.


Asunto(s)
Colesterol/sangre , Dieta con Restricción de Grasas , Sustitutos de Grasa/administración & dosificación , Posmenopausia/sangre , Anciano , Anciano de 80 o más Años , Análisis de Varianza , Animales , Apolipoproteínas/sangre , Apolipoproteínas/efectos de los fármacos , Peso Corporal , HDL-Colesterol/sangre , HDL-Colesterol/efectos de los fármacos , LDL-Colesterol/sangre , LDL-Colesterol/efectos de los fármacos , Estudios de Cohortes , Registros de Dieta , Grasas de la Dieta/administración & dosificación , Ingestión de Energía , Ácidos Grasos/metabolismo , Femenino , Humanos , Lípidos/sangre , Lipoproteínas/sangre , Lipoproteínas/efectos de los fármacos , Persona de Mediana Edad , Estaciones del Año , Factores de Tiempo , Triglicéridos/sangre
19.
Pharm Res ; 14(12): 1718-25, 1997 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9453059

RESUMEN

PURPOSE: Andersen Mark II cascade impactors are commonly used for the testing of pharmaceutical aerosols. The reproducibility of size distribution measurements made with various Mark II impactors was assessed theoretically and experimentally. METHODS: Stage cutpoints were calculated for fourteen Mark II impactors based on jet diameter measurements for each stage. The calculated cutpoints were used to predict differences in size distributions measured with various Mark II impactors. Five impactors were exposed to an atomizer-generated oleic acid test aerosol to experimentally verify predicted differences in size distribution measurements among impactors. RESULTS: Stage cutpoints were calculated to vary by up to 0.45 micron for 'identical' stages of different Mark II impactors based on jet diameter measurements. The size distributions measured with various Mark II impactors were shown to be significantly different based on theoretical and experimental observations. For one particular experiment, the amount of material collected on Stage 6 ranged from 26.8 percent of the total sampled mass to 40.9 percent depending on which Mark II was used. Theoretical calculations predicted that the amount of material collected on Stage 6 would vary from 24.0 to 43.5 percent of the total sampled mass among impactors for this experiment. A Similarity Ratio, useful for interpreting the test results, was defined and discussed. CONCLUSIONS: Significant differences in stage cutpoints exist among Andersen Mark II impactors. These differences in stage cutpoints can result in large differences in size distribution measurements made with various Mark II impactors. By measuring jet diameters and calculating stage cutpoints, it is possible to predict the performance of a particular Mark II impactor.


Asunto(s)
Aerosoles , Nebulizadores y Vaporizadores , Modelos Teóricos , Ácido Oléico , Tamaño de la Partícula , Reproducibilidad de los Resultados
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...